Stammdaten
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Unternehmen & Branche
| Name | BIOADAPTIVES, INC. |
|---|---|
| Ticker | BDPT |
| CIK | 0001575142 |
| Boerse | US |
| Sektor | Consumer Defensive |
| Industrie | Packaged Foods |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 91.390 USD |
| Beta | 1,34 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 18,278 | -1,557,898 | -0.15 | 225,901 | -2,130,056 |
| 2025-09-30 | 10-Q | 4,632 | -379,502 | -0.04 | 124,360 | -1,465,210 |
| 2025-06-30 | 10-Q | 3,219 | -157,914 | 0.02 | 272,515 | -1,231,298 |
| 2025-03-31 | 10-Q | 0 | -197,136 | -0.02 | 110,448 | -1,571,054 |
| 2024-12-31 | 10-K | 12,669 | -899,161 | -0.11 | 261,885 | -1,463,918 |
| 2024-09-30 | 10-Q | 0 | -37,649 | 0.00 | 46,393 | -1,805,361 |
| 2024-06-30 | 10-Q | 675 | -183,017 | 0.06 | 8,735 | -1,867,712 |
| 2024-03-31 | 10-Q | 11,994 | -306,707 | -0.04 | 58,667 | -1,797,883 |
| 2023-12-31 | 10-K | 28,565 | -712,466 | 103,998 | -1,646,631 | |
| 2023-09-30 | 10-Q | 15,649 | -13,061 | 329,302 | -1,145,848 | |
| 2023-06-30 | 10-Q | 2,339 | -143,917 | 48,273 | -1,678,512 | |
| 2023-03-31 | 10-Q | 3,376 | -287,187 | 13,039 | -1,630,652 | |
| 2022-12-31 | 10-K | 17,176 | -895,570 | 37,314 | -1,451,501 | |
| 2022-09-30 | 10-Q | 3,337 | -276,325 | 29,615 | -1,595,858 | |
| 2022-06-30 | 10-Q | 4,322 | -223,837 | 69,377 | -1,494,946 | |
| 2022-03-31 | 10-Q | 5,533 | -367,131 | 87,072 | -1,398,153 | |
| 2021-12-31 | 10-K | 19,776 | -1,049,948 | 148,585 | -1,093,039 | |
| 2021-09-30 | 10-Q | 5,342 | -34,516 | 178,695 | -1,212,286 | |
| 2021-06-30 | 10-Q | 6,065 | -309,246 | 135,971 | -1,351,922 | |
| 2021-03-31 | 10-Q | 4,518 | -491,903 | 121,918 | -1,042,676 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.